We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+10.89%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$36.2B
AUM Growth
+$2.03B
(+6%)
Cap. Flow
-$1.03B
Cap. Flow
% of AUM
-2.85%
Top 10 Holdings %
Top 10 Hldgs %
14.34%
Holding
2,349
New
214
Increased
749
Reduced
1,086
Closed
196
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$165M |
| 2 |
American Electric Power
AEP
|
+$143M |
| 3 |
Duke Energy
DUK
|
+$123M |
| 4 |
Medtronic
MDT
|
+$121M |
| 5 |
Eli Lilly
LLY
|
+$86.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$211M |
| 2 |
Chevron
CVX
|
+$186M |
| 3 |
STOR
STORE Capital Corporation
STOR
|
+$172M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$169M |
| 5 |
ExxonMobil
XOM
|
+$168M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.91% |
| 2 | Financials | 14.92% |
| 3 | Technology | 12.39% |
| 4 | Consumer Discretionary | 8.32% |
| 5 | Consumer Staples | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
PDS Biotechnology
PDSB
$35.3M
| $3.77K | ﹤0.01% |
286
-749
| -72% | -$5.28K |
|
|
ZUO
1952
DELISTED
Zuora, Inc.
ZUO
| $3.73K | ﹤0.01% |
+586
| New | +$4.14K |
|
|
ASRT
1953
DELISTED
Assertio
ASRT
| $3.71K | ﹤0.01% |
57
-9
| -14% | -$396 |
|
1954
QuantumScape Corp
QS
$3.16B
| $3.64K | ﹤0.01% |
642
-21
| -3% | -$156 |
|
1955
Pathward Financial
CASH
$1.63B
| $3.62K | ﹤0.01% |
84
| – | – |
|
|
PBPB
1956
DELISTED
Potbelly
PBPB
| $3.62K | ﹤0.01% |
649
+392
| +153% | +$2.06K |
|
|
JNCE
1957
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $3.6K | ﹤0.01% |
3,239
+2,929
| +945% | +$4.17K |
|
1958
AerSale
ASLE
$257M
| $3.55K | ﹤0.01% |
219
| – | – |
|
|
ARC
1959
DELISTED
ARC Document Solutions, Inc.
ARC
| $3.53K | ﹤0.01% |
1,206
-106
| -8% | -$281 |
|
1960
Oric Pharmaceuticals
ORIC
$1.27B
| $3.39K | ﹤0.01% |
575
+141
| +32% | +$476 |
|
1961
Clarivate
CLVT
$1.2B
| $3.3K | ﹤0.01% |
+396
| New | +$3.72K |
|
|
SMLR
1962
DELISTED
Semler Scientific
SMLR
| $3.27K | ﹤0.01% |
99
-135
| -58% | -$4.68K |
|
|
NUVL
1963
DELISTED
Nuvalent
NUVL
| $3.25K | ﹤0.01% |
+109
| New | +$3.04K |
|
1964
IBEX
IBEX
$538M
| $3.23K | ﹤0.01% |
+130
| New | +$2.93K |
|
1965
Oil States International
OIS
$518M
| $3.19K | ﹤0.01% |
427
-72
| -14% | -$445 |
|
1966
Monolithic Power Systems
MPWR
$56B
| $3.18K | ﹤0.01% |
9
-29
| -76% | -$10.4K |
|
|
OSG
1967
Octave Specialty Group
OSG
$222M
| $3.16K | ﹤0.01% |
+181
| New | +$2.69K |
|
1968
Employers Holdings
EIG
$899M
| $3.15K | ﹤0.01% |
73
+33
| +83% | +$1.36K |
|
1969
Champion Homes
SKY
$4.53B
| $3.09K | ﹤0.01% |
60
+17
| +40% | +$905 |
|
1970
ING
ING
$104B
| $3.08K | ﹤0.01% |
253
| – | – |
|
|
SNCR
1971
DELISTED
Synchronoss Technologies
SNCR
| $3.05K | ﹤0.01% |
548
+204
| +59% | +$1.68K |
|
1972
Aligos Therapeutics
ALGS
$31.7M
| $3.03K | ﹤0.01% |
127
+46
| +57% | +$1.16K |
|
|
TRUE
1973
DELISTED
TrueCar
TRUE
| $3.02K | ﹤0.01% |
1,205
-550
| -31% | -$1.14K |
|
1974
Vera Bradley
VRA
$114M
| $2.99K | ﹤0.01% |
661
-752
| -53% | -$2.75K |
|
1975
Masco
MAS
$13.5B
| $2.99K | ﹤0.01% |
64
-210,260
| -100% | -$10.1M |
|
Similar funds
Federated Hermes's Q4 2022 Portfolio in Review
As of Q4 2022, Federated Hermes held 2,349 positions worth $36.2B, up 6% from $34.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Federated Hermes's Q4 2022 filing shows 214 new, 749 increased, 1,086 reduced and 196 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 310,000 shares worth $26.2M. The largest sale was Amgen, an estimated $211M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Financials and Technology.
- Federated Hermes's largest Q4 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 310,000 shares worth $26.2M.
- Federated Hermes added most to LyondellBasell Industries in Q4 2022, an estimated $165M increase.
- Federated Hermes's biggest Q4 2022 reduction was Amgen, cutting an estimated $211M.
- Federated Hermes fully exited Akouos Inc in Q4 2022, selling an estimated $27M.
- Federated Hermes's ten largest holdings make up 14% of its $36.2B portfolio in Q4 2022.
- Federated Hermes opened 214 new positions and closed 196 in Q4 2022.
- Federated Hermes's portfolio value rose 6% quarter-over-quarter to $36.2B.
Based on Federated Hermes's 13F filing for Q4 2022, filed 13 Feb 2023.